Is Neogen Stock a Good Investment?
Neogen Investment Advice | NEOG |
- Examine Neogen's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Neogen's leadership team and their track record. Good management can help Neogen navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Neogen's business and its evolving consumer preferences.
- Compare Neogen's performance and market position to its competitors. Analyze how Neogen is positioned in terms of product offerings, innovation, and market share.
- Check if Neogen pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Neogen's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Neogen stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Neogen is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Neogen Stock
Researching Neogen's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 100.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.92. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neogen has Price/Earnings To Growth (PEG) ratio of 0.66. The entity recorded a loss per share of 2.19. The firm had not issued any dividends in recent years. Neogen had 2:1 split on the 7th of June 2021.
To determine if Neogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Neogen's research are outlined below:
| Neogen generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 924.22 M. Net Loss for the year was (9.42 M) with profit before overhead, payroll, taxes, and interest of 455.96 M. | |
| Neogen has a poor financial position based on the latest SEC disclosures | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Acquisition by John Adent of 23035 shares of Neogen at 11.03 subject to Rule 16b-3 |
Neogen Quarterly Gross Profit |
|
Neogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Neogen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Neogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 25th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of July 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Neogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Neogen's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-08 | 2024-08-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2016-12-21 | 2016-11-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2016-03-23 | 2016-02-29 | 0.09 | 0.08 | -0.01 | 11 | ||
2015-12-21 | 2015-11-30 | 0.1 | 0.09 | -0.01 | 10 | ||
2015-09-21 | 2015-08-31 | 0.1 | 0.09 | -0.01 | 10 | ||
2015-03-26 | 2015-02-28 | 0.09 | 0.08 | -0.01 | 11 | ||
2013-07-23 | 2013-05-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2012-07-24 | 2012-05-31 | 0.07 | 0.06 | -0.01 | 14 |
Neogen Target Price Consensus
Neogen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Neogen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Neogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Neogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Neogen, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationNeogen Target Price Projection
Neogen's current and average target prices are 11.56 and 15.75, respectively. The current price of Neogen is the price at which Neogen is currently trading. On the other hand, Neogen's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Neogen Target Price
Neogen Analyst Ratings
Neogen's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Neogen stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Neogen's financials, market performance, and future outlook by experienced professionals. Neogen's historical ratings below, therefore, can serve as a valuable tool for investors.Know Neogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Neogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neogen backward and forwards among themselves. Neogen's institutional investor refers to the entity that pools money to purchase Neogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 5.6 M | T. Rowe Price Investment Management,inc. | 2024-09-30 | 5.6 M | Geode Capital Management, Llc | 2024-09-30 | 5.1 M | King Luther Capital Management Corp | 2024-09-30 | 5.1 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 4.7 M | Fred Alger Management, Llc | 2024-09-30 | 4 M | Blair William & Co | 2024-09-30 | 3.8 M | Northern Trust Corp | 2024-09-30 | 3.6 M | Hhg Plc | 2024-09-30 | 3.6 M | Blackrock Inc | 2024-09-30 | 25.5 M | Vanguard Group Inc | 2024-09-30 | 19.7 M |
Neogen's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.52 B.Market Cap |
|
Neogen's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.01 | 0.01 |
Determining Neogen's profitability involves analyzing its financial statements and using various financial metrics to determine if Neogen is a good buy. For example, gross profit margin measures Neogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Neogen's profitability and make more informed investment decisions.
Neogen's Earnings Breakdown by Geography
Evaluate Neogen's management efficiency
The Neogen's current Return On Tangible Assets is estimated to increase to -0.0089. The current Return On Capital Employed is estimated to decrease to 0.01. At this time, Neogen's Other Current Assets are most likely to increase significantly in the upcoming years. The Neogen's current Total Current Assets is estimated to increase to about 711.5 M, while Other Assets are projected to decrease to 1.09. Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.07 | 13.73 | |
| Tangible Book Value Per Share | (2.09) | (1.99) | |
| Enterprise Value Over EBITDA | 17.66 | 16.26 | |
| Price Book Value Ratio | 0.81 | 0.77 | |
| Enterprise Value Multiple | 17.66 | 16.26 | |
| Price Fair Value | 0.81 | 0.77 | |
| Enterprise Value | 3.2 B | 3.4 B |
The management team at Neogen has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 1.223 |
Basic technical analysis of Neogen Stock
As of the 17th of January 2025, Neogen secures the Mean Deviation of 2.27, standard deviation of 2.85, and Risk Adjusted Performance of (0.08). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neogen, as well as the relationship between them. Please verify Neogen information ratio and potential upside to decide if Neogen is priced some-what accurately, providing market reflects its recent price of 11.56 per share. Given that Neogen has information ratio of (0.10), we recommend you to check Neogen's last-minute market performance to make sure the company can sustain itself at a future point.Neogen's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neogen's Outstanding Corporate Bonds
Neogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Neogen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Neogen bonds can be classified according to their maturity, which is the date when Neogen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| TNEMAK 3625 28 JUN 31 Corp BondUS64045DAC83 | View | |
| US64049MAB63 Corp BondUS64049MAB63 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Understand Neogen's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Neogen's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 2.27 | |||
| Coefficient Of Variation | (982.35) | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.11 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 12.51 | |||
| Value At Risk | (5.43) | |||
| Potential Upside | 3.99 | |||
| Skewness | (0.46) | |||
| Kurtosis | (0.20) |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 2.27 | |||
| Coefficient Of Variation | (982.35) | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.11 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 12.51 | |||
| Value At Risk | (5.43) | |||
| Potential Upside | 3.99 | |||
| Skewness | (0.46) | |||
| Kurtosis | (0.20) |
Consider Neogen's intraday indicators
Neogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Neogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 183613.0 | |||
| Daily Balance Of Power | (0.07) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 11.63 | |||
| Day Typical Price | 11.6 | |||
| Price Action Indicator | (0.09) | |||
| Period Momentum Indicator | (0.04) |
Neogen Corporate Filings
F4 | 16th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 15th of January 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 10th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 17th of December 2024 An amendment to a previously filed Form 8-K | ViewVerify |
Neogen Stock media impact
Far too much social signal, news, headlines, and media speculation about Neogen that are available to investors today. That information is available publicly through Neogen media outlets and privately through word of mouth or via Neogen internal channels. However, regardless of the origin, that massive amount of Neogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Neogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neogen alpha.
Neogen Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Neogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Neogen Corporate Management
| John Moylan | Corporate VP | Profile | |
| Bill Waelke | Head Relations | Profile | |
| Julie Mann | VP Officer | Profile | |
| Amy Rocklin | Chief Secretary | Profile | |
| David Naemura | Chief Officer | Profile | |
| Sarah Demey | Administrative Manager | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (2.19) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Neogen's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.